Catalyst Pharmaceutical Partners (CPRX -2.4%) says it's issued 6,666,667 shares of its...

|About: Catalyst Pharmaceutical Par... (CPRX)|By:, SA News Editor

Catalyst Pharmaceutical Partners (CPRX -2.4%) says it's issued 6,666,667 shares of its authorized but unissued common stock to BioMarin Pharmaceutical (BMRN +2.5%) upon the automatic conversion of a $5M loan that CPRX received from BMRN in October in connection with it's licensing of the North American rights to Firdapse. The shares were issued at a conversion price of $0.75 per share.